Method for isolating biomolecules from a biological sample with linear polymers
AssigneeMiddlesex Sciences, Inc.
InventorsJames E. Woiszwillo, Fred Rothstein
Life of this patent
Estimating the term…
Abstract
A method, composition, and kit for isolating biomolecules from a biological sample wherein the sample is mixed with a soluble, linear polymer, such as polyvinylpyrrolidone, to form a precipitate. The biomolecule of interest is found in the precipitate or is isolated from the supernatant.
Claims11
A method of isolating at least one biomolecule from a biological sample comprising the steps of:
- a) adding a sufficient amount of a solution of at least two soluble, linear polymers to a biological sample solution to form a precipitate, wherein a first polymer is polyvinylpyrrolidone and a second polymer is selected from the group consisting of polyethylene glycol, dextran, nonylphenol-ethoxylates, polyvinyl alcohol, and mixtures thereof, and adjusting the solution to a predetermined pH;
- and
- b) separating the solution into two fractions, a supernatant and a precipitate, wherein the biomolecule is isolated from either the supernatant or precipitate.
An assay for determining the albumin to globulin ratio in plasma comprising the steps of:
- a) adding a sufficient amount of a polymer solution of polyvinylpyrrolidone and polyethylene glycol to the plasma to precipitate the globulin, leaving the albumin in the supernatant, wherein the pH of the plasma is adjusted to an approximately neutral pH;
- b) separating the precipitate from the supernatant;
- c) measuring the concentrations of globulin and albumin;
- and
- d) calculating the ratio of albumin to globulin.
A method for determining the disposition of a drug in serum proteins comprising the steps of:
- a) adding a sufficient amount of an aqueous solution of polyvinylpyrrolidone and polyethylene glycol to serum to precipitate the globulin, and adjusting the pH of the serum to a predetermined value;
- b) separating the solution into two fractions, a supernatant fraction and a precipitate fraction wherein the globulin-bound drug is isolated from the precipitate fraction and the albumin-bound drug is isolated from the supernatant fraction;
- and
- c) analyzing the precipitate and supernatant fractions to detect the drug.
A method for dissolving a protein, precipitated from a biological sample, comprising:
- a) adding a sufficient amount of a solution of at least two soluble, linear polymers to a biological sample solution to form a precipitate, wherein a first polymer is polyvinylpyrrolidone and a second polymer is selected from the group consisting of polyethylene glycol, dextran, nonylphenol-ethoxylates, polyvinyl alcohol, and mixtures thereof;
- and adjusting the solution to a predetermined pH;
- b) separating the solution into two fractions, a supernatant and a precipitate, wherein the biomolecule is isolated from the precipitate;
- and
- c) dissolving the precipitated protein in an aqueous alkaline solution.
Dependencies are inferred from the claim text.